Confluence Wealth Management LLC raised its stake in Clorox Co (NYSE:CLX) by 34.9% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 2,862 shares of the company’s stock after acquiring an additional 741 shares during the quarter. Confluence Wealth Management LLC’s holdings in Clorox were worth $430,000 as of its most recent SEC filing.

A number of other large investors also recently added to or reduced their stakes in CLX. Cornerstone Wealth Management LLC purchased a new position in Clorox in the second quarter valued at about $105,000. Fort L.P. purchased a new position in Clorox in the second quarter valued at about $129,000. Livingston Group Asset Management CO operating as Southport Capital Management purchased a new position in Clorox in the third quarter valued at about $130,000. Whittier Trust Co. of Nevada Inc. raised its position in Clorox by 1,297.4% in the second quarter. Whittier Trust Co. of Nevada Inc. now owns 1,621 shares of the company’s stock valued at $148,000 after purchasing an additional 1,505 shares during the period. Finally, Legacy Advisors LLC purchased a new position in Clorox in the third quarter valued at about $150,000. 78.36% of the stock is currently owned by institutional investors.

NYSE:CLX opened at $150.85 on Tuesday. The stock has a market capitalization of $19.48 billion, a P/E ratio of 26.67, a PEG ratio of 3.64 and a beta of 0.36. Clorox Co has a one year low of $113.57 and a one year high of $154.51. The company has a debt-to-equity ratio of 3.15, a current ratio of 1.09 and a quick ratio of 0.67.

Clorox (NYSE:CLX) last posted its quarterly earnings results on Thursday, August 2nd. The company reported $1.66 EPS for the quarter, topping the Zacks’ consensus estimate of $1.58 by $0.08. The business had revenue of $1.69 billion during the quarter, compared to the consensus estimate of $1.72 billion. Clorox had a return on equity of 103.18% and a net margin of 13.44%. The company’s revenue for the quarter was up 2.7% compared to the same quarter last year. During the same period last year, the firm earned $1.53 earnings per share. On average, analysts predict that Clorox Co will post 6.41 EPS for the current year.

The company also recently declared a quarterly dividend, which will be paid on Friday, November 16th. Investors of record on Wednesday, October 31st will be paid a $0.96 dividend. The ex-dividend date of this dividend is Tuesday, October 30th. This represents a $3.84 dividend on an annualized basis and a yield of 2.55%. Clorox’s dividend payout ratio (DPR) is 61.34%.

In other Clorox news, EVP Linda J. Rendle sold 382 shares of Clorox stock in a transaction that occurred on Thursday, September 6th. The stock was sold at an average price of $148.32, for a total value of $56,658.24. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, COO Dawn C. Willoughby sold 3,387 shares of Clorox stock in a transaction that occurred on Wednesday, September 5th. The shares were sold at an average price of $148.01, for a total value of $501,309.87. The disclosure for this sale can be found here. Insiders sold 29,268 shares of company stock valued at $4,196,686 over the last quarter. Insiders own 1.40% of the company’s stock.

CLX has been the topic of several research reports. Zacks Investment Research lowered Clorox from a “buy” rating to a “hold” rating in a research report on Friday, October 5th. ValuEngine raised Clorox from a “hold” rating to a “buy” rating in a research report on Saturday, September 22nd. Argus raised Clorox from a “hold” rating to a “buy” rating and set a $175.00 price objective on the stock in a research report on Tuesday, September 25th. BMO Capital Markets restated a “buy” rating and set a $153.00 target price on shares of Clorox in a research note on Friday, August 3rd. Finally, Goldman Sachs Group downgraded Clorox from a “neutral” rating to a “sell” rating and lowered their target price for the company from $127.00 to $112.00 in a research note on Tuesday, July 17th. They noted that the move was a valuation call. Four research analysts have rated the stock with a sell rating, eight have given a hold rating and four have given a buy rating to the company’s stock. Clorox presently has a consensus rating of “Hold” and an average price target of $138.29.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.

See Also: What is the Rule of 72?

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.